Gene Query: UTP15

Dataset Description Geneva Score
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 22.61
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 19.89
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 19.81
FBXW7 modulates stress response by post-translational modification of HSF1 19.68
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 19.68
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 15.8
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 14.95
Hypoxic transcriptome of SQ20B human head and neck cancer cells 14.84
Knockdown of ADNP in HCT116 colon cancer cells 13.19
RNAseq Analysis in glioblastoma cells treated with Mepazine 12.78
Lysine benzoylation is a novel histone mark [RNA-seq] 12.5
Lysine benzoylation is a novel histone mark 12.5
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 12.36
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 12.15
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 12.1
R430: A potent inbibitor of DNA and RNA viruses 11.98
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 11.68
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 11.62
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 11.44
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 11.29
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 11.05
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 10.99
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 10.47
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 10.47
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 10.34
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 10.24
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 10.14
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 10.14
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 9.84
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 9.84
LNCaP treated with iBET 9.67
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 9.65
Developmental stage specific chromosome architecture in human erythroid cells 9.63
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 9.63
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 9.55
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 9.45
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 9.45
Transcriptome analysis upon C6orf203 silencing 9.3
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 9.15
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 9.09
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 9.06
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 8.58
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 8.5
Human HAP1 cells before and after nutrient deprivation 8.5
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 8.45
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 8.35
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 8.21
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 8.21
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 8.16
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 7.99
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 7.84
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 7.8
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 7.76
The landscape of alternative splicing in aggressive prostate cancers 7.74
Human cell line and subcutaneous tumor 7.57
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 7.53
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 7.42
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 7.4
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 7.37
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 7.28
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 7.28
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 7.27
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 7.27
Seletive inhibition of CDK9 in DLBCL cell lines 7.26
Single-nucleotide-resolution mapping of HBV promoters using CAGE 7.21
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 7.19
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 7.16
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 7.05
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 7.05
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 7.02
SLIGRL-induced gene expression changes in NHEK cells 6.83
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 6.82
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 6.67
Polarized B -cell functions 6.64
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 6.49
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 6.49
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 6.41
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 6.34
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 6.32
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 6.29
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 6.29
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.28
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 6.21
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 6.11
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 6.04
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 6.04
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 6.03
A transcriptome-wide divergence in protein translation scales with LIN28B expression 6.01
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 6.0
JunB control of keratinocyte-mediated inflammation [RNA-seq] 6.0
PNET animal model: new insights (II) 5.99
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 5.97
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 5.87
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.86
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 5.86
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 5.8
Cleavage Factor Im as a key regulator of 3’ UTR length 5.78
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 5.78
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 5.71
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 5.68
Total RNA-seq in ALL-SIL upon TLX1 knockdown 5.55
High-throughput sequencing of PROMPT-enriched samples. 5.54
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 5.52
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 5.46
ARID1A regulates condensin II distribution and chromosomal partition 5.45
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 5.45
Real-time observation of light-controlled transcription in living cells 5.4
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 5.38
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 5.36
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 5.32
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 5.31
Control of prostate tumour growth by the long non-coding RNA GHSROS 5.29
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 5.27
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 5.26
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 5.23
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 5.23
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 5.21
Identification of Nrf2 regulated genes by RNA sequencing 5.17
Nrf2 regulated genes in A549 cells 5.17
Cajal bodies are linked to genome conformation [RNA-Seq] 5.16
Cajal bodies are linked to genome conformation 5.16
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 5.16
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 5.15
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 5.13
TGF-β regulation of miRNA expression in pancreatic cancer 5.11
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.07
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 5.07
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 5.07
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 5.05
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 5.05
Transcriptome analysis of H9 hESC derived cerebral organoids 5.04
6mer seed toxicity in tumour suppressive microRNAs 5.02
RNA-seq of resting and activated CD4+ T cells +-JQ1 5.0
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.97
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 4.96
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 4.95
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 4.94
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 4.92
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.91
Capturing the Interactome of Newly Transcribed RNA 4.91
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 4.86
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 4.84
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 4.8
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 4.77
Hijacking of stress response machinery by oncogenes in acute leukaemia 4.77
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 4.77
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 4.74
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 4.74
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 4.74
Identification of HOXB13 target genes responsive to BET inhibitors 4.73
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 4.72
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 4.72
Uridylation by TUT4 and TUT7 marks mRNA for degradation 4.71
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 4.7
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 4.69
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 4.65
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 4.63
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 4.63
Effect of drugs on transcriptomic profiles 4.63
Regulation of protein translation during mitosis 4.59
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.59
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.59
Identification of transcription start sites for human A549 cell line using ReCappable-seq 4.58
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 4.55
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 4.48
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 4.43
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 4.35
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 4.3
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 4.29
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 4.29
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 4.28
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 4.26
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 4.26
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 4.25
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 4.19
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 4.19
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 4.16
Genome-wide discovery of human splicing branchpoints [RNAse] 4.16
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 4.13
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 4.12
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 4.11
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 4.11
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 4.11
Differentially expressed genes post knock down of lincDUSP26 4.1
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 4.09
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 4.08
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 4.04
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 4.0
p53 activity results in DNA replication fork processivity 3.99
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 3.98
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 3.97
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 3.97
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 3.97
RNA-Sequencing of HepG2 cells treated with TGFBeta 3.97
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 3.96
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.95
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 3.93
Transcriptomic analyssis following EHMT1/2 inhibition 3.93
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 3.91
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 3.91
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 3.9
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 3.9
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.89
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 3.85
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 3.85
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 3.83
ChIP-seq and RNA-seq from human lymphoma cell lines 3.82
RNA-seq data from human lymphoma cell lines 3.82
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 3.82
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.79
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 3.78
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 3.78
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.77
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 3.76
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 3.74
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 3.72
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 3.71
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 3.7
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 3.69
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.69
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 3.68
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 3.68
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.68
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 3.67
MYC dependent mRNA translation shapes gene expression and cell biology 3.67
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 3.58
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 3.57
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 3.57
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 3.57
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.56
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 3.55
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 3.52
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 3.5
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 3.49
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 3.48
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 3.44
RNA seq with AML (NB4) cells upon FTO inhibition 3.42
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.42
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 3.42
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.41
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 3.39
The Genetic Landscape of Diamond-Blackfan Anemia 3.38
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 3.35
Functional role of SLIT2 and ROBO1 in trophoblasts 3.35
Effect of from Human Umbilical Vein Endothelial Cells 3.34
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 3.33
SLAM-seq for K562 endogenous mRNA decay 3.31
RNA-seq of MDA-MB-231 cells with TET1 knockout 3.28
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 3.26
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 3.24
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 3.23
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 3.23
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 3.22
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 3.2
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 3.19
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 3.18
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 3.17
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.17
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 3.15
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 3.13
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.12
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 3.11
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 3.09
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 3.06
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 3.05
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 3.05
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 3.05
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 3.05
RNA-seq analysis of control and Myc-induced U2OS cells 3.03
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.03
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.01
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 3.01
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 3.01
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 3.01
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 3.01
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 3.01
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.98
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 2.98
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 2.95
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 2.95
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.94
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 2.93
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.92
Identification of Sin3B regulated genes during quiescence 2.88
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.87
Transcriptional landscape changes during human embryonic stem cell derivation 2.85
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 2.85
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 2.85
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 2.84
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 2.84
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 2.84
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 2.83
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.8
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.8
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.8
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 2.78
Regulation of poly(A) tail and translation during the somatic cell cycle 2.78
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.77
Transcriptome of activated human and mouse MAIT cells 2.76
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.74
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 2.74
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 2.74
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 2.7
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 2.67
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 2.66
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.64
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 2.59
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.56
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.56
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 2.55
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 2.55
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 2.55
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 2.52
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 2.51
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.5
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 2.44
Analysis of transcriptional regulation by Myt1 and Myt1l 2.43
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 2.41
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 2.39
PRDM1 inhibits proliferation of human colon cancer organoids 2.36
Functional significance of the HIV-1 Tat signature amino acid residues 2.36
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.35
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.34
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.31
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 2.28
RNA sequencing of matched nephrectomy samples [RNA-seq] 2.27
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 2.27
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 2.24
RNA sequencing of human mammary epithelial cells 2.24
RNA-seq of RKO cells with cTAZ KO or putback 2.23
Cell responses to dysregulated VZV-induced cell-cell fusion 2.21
Integrin signaling regulates YAP/TAZ to control skin homeostasis 2.19
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.18
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.18
Effect of PBK knockdown on C4-2 cell transcriptome 2.18
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 2.17
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.15
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 2.13
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.1
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 2.1
SRSF1 role in cellular gene expression and splicing 2.09
In vitro modeling of human germ cell development using pluripotent stem cells 2.08
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.07
Effect of BB608 on Gene Expression in HNSCC Cell Line 2.07
The cytokine environment influence on human skin-derived T cells 2.02
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 2.0
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 2.0
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.97
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.96
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.94
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.94
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 1.93
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 1.92
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 1.92
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.92
Gene expression profile in breast cancer cells 1.87
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.87
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 1.85
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.85
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.84
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 1.84
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.84
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.83
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.81
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.81
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.79
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 1.77
Primary Human B-cell Temporal Response to CD40L Stimulation 1.76
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 1.75
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.74
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 1.73
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 1.71
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.71
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.71
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.71
Human Treg NaCl stimulation 1.69
Genome-wide analysis of the Integrator complex (HTS) 1.69
Genome-wide analysis of the Integrator complex 1.69
Role of COP1 on MAP kinase transcriptional output in melanoma 1.62
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.62
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.61
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.57
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.56
U2AF1 mutations alter splice site recognition in hematological malignancies 1.55
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 1.53
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.48
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.48
KSDM1b Role in Ewing Sarcoma 1.48
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.47
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.46
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.45
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.45
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.43
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.43
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.41
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.38
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.38
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 1.37
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 1.37
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.36
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.34
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.33
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.3
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.3
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 1.29
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 1.28
6mer seed toxicity in viral microRNAs 1.27
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 1.25
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.22
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.22
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.22
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.22
Effect of PRDM11 depletion in U2932 cells 1.22
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.21
An siRNA screen identifies CHD4 as a target for epigenetic therapy 1.2
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.19
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.19
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.12
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.11
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 1.11
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.09
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.09
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 1.08
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.07
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.07
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 1.06
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.05
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 1.02
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.02
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 0.95
HBEC-shp53-PCHD7 0.93
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 0.92
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.9
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 0.89
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 0.89
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.87
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.86
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 0.84
High-resolution comparative analysis of great ape genomes 0.83
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.82
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.8
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.74
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.73
Myc activation coordinates gene transcription and protein translation responses 0.71
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 0.7
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.68
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.66
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.66
EWS-Fli and LNC regulated genes in comparison to GFP samples 0.65
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.64
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.64
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.63
Modulation of nonsense-mediated decay by rapamycin 0.62
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.6
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.6
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.59
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.59
O-glcnAc reprograms cellular energetics 0.55
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.55
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.55
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.52
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.51
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.5
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.5
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.48
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.45
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.4
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.39
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.39
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.39
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.37
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.36
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.36
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.34
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.33
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.33
Human Treg IL-12 stimulation 0.32
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.29
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 0.29
siRNA-mediated knockdown 0.28
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.26
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.23
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.23
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.21
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.18
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.17
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 0.17
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.16
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.14
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.11
Loss of CREBBP results in gene expression repression in lymphoma cells 0.09
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.09
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.08
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.07
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.06
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.05
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.04
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.01
The contribution of Alu exons to the human proteome 0.01
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation